BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 48 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $975,869 | +267.1% | 950,000 | +280.0% | 0.00% | – |
| Q4 2022 | $265,828 | -42.1% | 250,000 | -45.8% | 0.00% | – |
| Q3 2022 | $459,000 | +3.1% | 461,000 | +2.4% | 0.00% | – |
| Q2 2022 | $445,000 | -1.8% | 450,000 | 0.0% | 0.00% | – |
| Q1 2022 | $453,000 | -4.2% | 450,000 | 0.0% | 0.00% | – |
| Q4 2021 | $473,000 | -45.8% | 450,000 | -47.1% | 0.00% | – |
| Q3 2021 | $873,000 | -1.4% | 850,000 | 0.0% | 0.00% | – |
| Q2 2021 | $885,000 | +1.7% | 850,000 | 0.0% | 0.00% | – |
| Q1 2021 | $870,000 | -5.0% | 850,000 | 0.0% | 0.00% | – |
| Q4 2020 | $916,000 | +3.2% | 850,000 | 0.0% | 0.00% | – |
| Q3 2020 | $888,000 | -14.9% | 850,000 | 0.0% | 0.00% | – |
| Q2 2020 | $1,043,000 | +121.9% | 850,000 | +88.9% | 0.00% | – |
| Q1 2020 | $470,000 | -48.3% | 450,000 | -47.6% | 0.00% | – |
| Q4 2019 | $909,000 | +7.4% | 858,000 | 0.0% | 0.00% | – |
| Q3 2019 | $846,000 | -5.2% | 858,000 | 0.0% | 0.00% | – |
| Q2 2019 | $892,000 | +1.1% | 858,000 | 0.0% | 0.00% | – |
| Q1 2019 | $882,000 | +4.6% | 858,000 | +0.9% | 0.00% | – |
| Q4 2018 | $843,000 | -6.9% | 850,000 | 0.0% | 0.00% | – |
| Q3 2018 | $905,000 | – | 850,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SHENKMAN CAPITAL MANAGEMENT INC | 23,984,000 | $24,566,321 | 1.87% |
| SSI INVESTMENT MANAGEMENT LLC | 14,019,000 | $14,383,199 | 1.01% |
| PFM Health Sciences, LP | 15,000,000 | $15,427,185 | 0.68% |
| Sonora Investment Management Group, LLC | 6,380,000 | $6,460,377 | 0.56% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 24,638,000 | $25,339,666 | 0.48% |
| Lombard Odier Asset Management (Europe) Ltd | 9,000,000 | $9,099,180 | 0.45% |
| RWC Asset Management LLP | 11,700,000 | $12,018,591 | 0.37% |
| MACKAY SHIELDS LLC | 10,450,000 | $10,721,491 | 0.29% |
| PALISADE CAPITAL MANAGEMENT, LP | 10,093,000 | $10,326,148 | 0.28% |
| Nicholas Investment Partners, LP | 2,940,000 | $3,016,378 | 0.23% |